Advertiser.ie - Galway-based neurovascular company Perfuze raises €22.5m Series A investment for new stroke treatment

Perfuze, a Galway-based medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5 million Series A investment round.

Related Keywords

Ireland ,Irish ,Daniel Omahony ,Megan Macdonagh ,Anne Portwich ,Dwayne Allen ,Health Economics Fund ,Partner At Seroba Life Sciences ,Sv Health Investors ,Medtech Convergence Fund ,Sv Health ,Seroba Life Sciences ,Economics Fund ,Seroba Life ,Medfocus Fund ,Enterprise Ireland ,Danielo Mahony ,Senior Associate ,Perfuze Millipede System ,Liam Mullins ,Embo Medical ,Geography Of Ireland ,Galway ,Eography Of Europe ,Connacht ,Administrative Divisions ,Stroke ,United States ,Health Medical Pharma ,Business Finance ,Daniel ,Ceo ,Catheter ,World Health Organization ,Life Saving Technology ,Medical Equipment ,Stroke Treatment ,Dvanced Medical Equipment Technology Nec ,Government Administration Activities ,Upplies Distribution Nec ,Leducq Foundation ,Hrombectomy Technology ,Iameter Aspiration Technology ,Ischemic Stroke ,Perfuze ,Atheter Based Aspiration Technology ,Cr Bard ,Ww Perfuze Com ,Uper Bore Diameter Aspiration Technology ,Illipede Technology ,Bm Medfocus Fund ,Acute Ischemic Stroke ,Sp Health Economics Fund ,